2025
17 September 2025
Ordem dos Farmacêuticos, Lisboa,
14:00-18:30
Programme
14:00
Check in
14:30
Welcome Session
Hélder Mota Filipe, President, Portuguese Pharmaceutical Society
Francisco Rocha Gonçalves, Secretary of State for Health Management
14:40
Tecnimede Open Innovation Competition & Jorge Ruas Award
Maria do Carmo Neves, Chair of the Board of Directors, Tecnimede Group
14:50
Science and Business: Bridges or Invisible Walls?
Roundtable with:
Hélder Mota Filipe, President, Portuguese Pharmaceutical Society
Maria do Carmo Neves, Chair of the Board of Directors, Tecnimede Group
Amílcar Falcão, Rector, University of Coimbra
António Murta, Managing Partner, Co-founder and CEO, Pathena
Carlos Robalo Cordeiro, Dean, Faculty of Medicine, University of Coimbra
15:30
Presentation of the 10 Finalist Projects
AAV-Based Gene Therapy for PPMS | Glioblastoma Treatment Innovation | GnRHope | iPLUS | mFibro | NEXOLIVAD | Optomics® Technology | PURR.AI’s AGELESS Platform | Reventus Pharma | Targeting VGF Receptor Signalling for Brain Metastasis
17:30
Coffee break & Networking
18:00
Jorge Ruas Award Announcement and Presentation
18:15
Closing Remarks
Rui Santos Ivo, President of the Board of Directors, INFARMED, I.P.
